Cornell College Events

Van Tompkins, Ph. D., received his doctorate in 2007 from the department of pharmacology at the University of Iowa, and is currently pursuing postdoctoral studies in the UI department of pathology. Dr. Tompkins has been studying the role of the protein NIAM in B cell and plasma cell cancers such as lymphoma and multiple myeloma. NIAM can suppress cellular growth and enhance genomic stability and research suggests that NIAM could be a tumor suppressor. The purpose of Dr. Tompkins’s work is to examine the hypothesis that NIAM suppresses B cell neoplastic development and enhances treatment outcome. His work is supported by an American Cancer Society Postdoctoral Fellowship.